Recurrent rhabdomyolysis during dabrafenib and trametinib therapy in BRAF V600E-mutated non-small cell lung cancer: a case report

Current Problems in Cancer: Case Reports · Published 2026-06-14 · DOI 10.1016/j.cpccr.2026.100429

Free full text

Authors (5)

Makina Yamagata, Hiromitsu Ohta, Hikari Amari, Jyun Shiihara, Yasuhiro Yamaguchi

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Yamagata, M., Ohta, H., Amari, H., et al. (2026). Recurrent rhabdomyolysis during dabrafenib and trametinib therapy in BRAF V600E-mutated non-small cell lung cancer: a case report. Current Problems in Cancer: Case Reports. https://doi.org/10.1016/j.cpccr.2026.100429

Related articles